SHL Telemedicine Ltd.
SIX: SHLTN.SW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Swiss Exchange
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- David Arnon
- Employees
- 526
- Headquarters
- Tel Aviv, Israel
- IPO year
- 2000
- Market cap
- CHF 15.9M
- Website
- https://www.shl-telemedicine.com
Loading SHLTN…
Loading profile data…Frequently asked questions about SHLTN
What does SHL Telemedicine Ltd. (SHLTN.SW) do?
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a p...
Where does SHLTN.SW trade?
SHL Telemedicine Ltd. (SHLTN.SW) trades on the Swiss Exchange.
What sector is SHLTN.SW in?
SHL Telemedicine Ltd. (SHLTN.SW) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of SHL Telemedicine Ltd.?
David Arnon is the chief executive officer of SHL Telemedicine Ltd. (SHLTN.SW).
Where is SHL Telemedicine Ltd. headquartered?
SHL Telemedicine Ltd. is headquartered in Israel.
Does SHLTN.SW pay a dividend?
SHL Telemedicine Ltd. (SHLTN.SW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SHLTN.SW go public?
SHL Telemedicine Ltd. (SHLTN.SW) completed its initial public offering in 2000.